(Q40349299)

19 September 2017

title

Whither trial-based economic evaluation for health care decision making? (English)

1 reference

19 September 2017

1 reference

2

Karl Claxton

1 reference

19 September 2017

Mark J Sculpher

1

1 reference

19 September 2017

Mike Drummond

series ordinal

3

1 reference

19 September 2017

Chris McCabe

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

15

1 reference

19 September 2017

issue

7

1 reference

19 September 2017

page(s)

677-687

1 reference

Evidence based medicine: what it is and what it isn't

19 September 2017

cites work

1 reference

A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme

21 January 2018

1 reference

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

21 January 2018

1 reference

Health economic guidelines--similarities, differences and some implications

21 January 2018

1 reference

7 January 2021

A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

1 reference

7 January 2021

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra

1 reference

7 January 2021

The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies

1 reference

7 January 2021

An economic approach to clinical trial design and research priority-setting

1 reference

7 January 2021

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

1 reference

7 January 2021

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

1 reference

7 January 2021

Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models

1 reference

7 January 2021

Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis

1 reference

7 January 2021

Using multilevel models for assessing the variability of multinational resource use and cost data.

1 reference

7 January 2021

1 reference

7 January 2021

Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?

1 reference

7 January 2021

Expected value of sample information calculations in medical decision modeling.

1 reference

7 January 2021

Problems of using modelling in the economic evaluation of health care

1 reference

7 January 2021

The journal's policy on cost-effectiveness analyses.

1 reference

7 January 2021

Modelling in the economic evaluation of health care: selecting the appropriate approach

1 reference

7 January 2021

Borrowing strength from external trials in a meta-analysis.

1 reference

7 January 2021

A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence

1 reference

7 January 2021

Meta-analysis of multiple outcomes by regression with random effects.

1 reference

7 January 2021

Markov chain Monte Carlo estimation of a multiparameter decision model: consistency of evidence and the accurate assessment of uncertainty.

1 reference

7 January 2021

Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke

1 reference

7 January 2021

Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach

1 reference

7 January 2021

How to develop cost-conscious guidelines.

1 reference

7 January 2021

A normative analytic framework for development of practice guidelines for specific clinical populations.

1 reference

7 January 2021

The iterative use of economic evaluation as part of the process of health technology assessment

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEC.1093

1 reference

19 September 2017

1 reference